Literature DB >> 2575570

Effect of apomorphine on adrenal medullary catecholamine levels.

J L Montastruc1, G Gaillard, O Rascol, M A Tran, P Montastruc.   

Abstract

The effects of the dopamine receptor agonist, apomorphine, on the total catecholamine content of the adrenal medulla were studied in normotensive rats. Apomorphine (3, 15, 30 mg/kg SC) induced a dose-dependent decrease in catecholamine content of the adrenal gland. The action of apomorphine was suppressed by previous treatment with the non specific dopamine receptor antagonist, haloperidol (9 mg/kg IP), or the D2 antagonist domperidone (2 mg/kg IP), but not by the D1 antagonist SCH 23390 (1 mg/kg IP). The apomorphine-induced decrease in adrenal catecholamine concentration was suppressed by denervation of the adrenal medulla, i.e. unilateral section of splanchnic fibers performed 5 days before. These results show that, under our experimental conditions, the effect of apomorphine is due to the activation of D2 dopamine receptors probably located on splanchnic nerve endings and suggest the existence of a peripheral D2 dopaminergic system which modulates adrenal medullary catecholamine content.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2575570     DOI: 10.1111/j.1472-8206.1989.tb00467.x

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN: 0767-3981            Impact factor:   2.748


  3 in total

1.  In vivo venodilator action of fenoldopam, a dopamine D(1)-receptor agonist.

Authors:  S S Ng; C C Pang
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

2.  I. c. v. dopamine fails to alter adrenomedullary function in rats.

Authors:  M Kujacic; A Carlsson
Journal:  J Neural Transm Gen Sect       Date:  1994

3.  Roles of dopaminergic d(1) and d(2) receptors in catecholamine release from the rat adrenal medulla.

Authors:  Young Joo Baek; Yoo Seong Seo; Dong Yoon Lim
Journal:  Korean J Physiol Pharmacol       Date:  2008-02-28       Impact factor: 2.016

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.